Document is current
Any future updates will be listed below
-
Authors
French, Jacqueline A. https://orcid.org/0000-0003-2242-8027
- License Information
-
More Information
Article History
First Online: 8 January 2020
Competing interests
: J.A.F. receives New York University salary support from the Epilepsy Foundation and for consulting work and/or attending Scientific Advisory Boards on behalf of the Epilepsy Study Consortium for Adamas, Aeonian/Aeovian, Anavex, Arvelle Therapeutics, Axovant, Biogen, BioMotiv/Koutif, Blackfynn, Bloom Science, BridgeValley, Cavion, Cerebral Therapeutics, Cerevel, Crossject, CuroNz, Eisai, Engage Therapeutics, Epitel, Fortress Biotech, GW Pharma, Idorsia, Ionis, Lundbeck, Marinus, Neurocrine, Otsuka Pharmaceutical Development, Ovid Therapeutics, Pfizer, Praxis, Redpin Therapeutics, Sage, Shire, SK Life Sciences, Springworks, Stoke, Sunovion, Supernus, Takeda, UCB, West Therapeutic Development, Xenon Pharmaceuticals and Zogenix.
